Developing curcumin into a viable therapeutic for lymphoma

Author： Uddin Shahab   Khan Asma S   Al-Kuraya Khawla S  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.1, 2009-01, pp. : 57-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Therapeutic Effects of Curcumin

By  

Current Pharmaceutical Design, Vol. 19, Iss. 11, 2013-04 ,pp. : 2032-2046

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin: a novel therapeutic for burn pain and wound healing

By Cheppudira Bopaiah   Fowler Marcie   McGhee Laura   Greer Angie   Mares Alberto   Petz Lawrence   Devore David   Loyd Dayna R   Clifford John L  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1295-1303

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase as a therapeutic target

By Kruczynski Anna   Delsol Georges   Laurent Camille   Brousset Pierre   Lamant Laurence  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite

Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?

By van Golen Kenneth L  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 709-721

Informa Healthcare

Access to resources Recommend Favorite

The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 293-302

Bentham Science Publishers

Access to resources Recommend Favorite